Gamified Acceptance & Commitment Therapy for Benzodiazepine Discontinuation: Randomised controlled trial
- Conditions
- Benzodiazepine Discontinuation
- Registration Number
- JPRN-UMIN000023580
- Lead Sponsor
- agoya City University Graduate School of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Not provided
1.Being regulary prescribed 3 types of benzodiazepine and over. (excluded required use or use for insomnia) 2.Actively satisfied diagnostic cliteria with Mini-International Neuropsychiatric Interview. 3.Being regularly prescribed antipsychotic or mood stabilizer (lithium, valproate, carbamazepine and lamotrigine) 4.Imminent risk of suicide as judged by the treating physician. 5.Currently participating in another clinical intervention study. 6. Family members living with the researchers of the present study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The success rate of benzodiazepine discontinuation during the 11th and 12th week after beginning of the program
- Secondary Outcome Measures
Name Time Method Benzodiazepine reduction rate,Recovery Assessment Scale(RAS),Depression Anxiety Stress Scale(DASS),Severity of Dependence syndrome(SDS),Euro Qol 5 Dimension(EQ5-D),Cognitive Fusion Questionnaire(CFQ),Personal Values Questionnaire II (PVQ-II)